Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 4713 | 1665 | 48.2 | 94% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 313 | 17635 | X LINKED AGAMMAGLOBULINEMIA//BRUTONS TYROSINE KINASE//BTK |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PEPTIDE MHC | Author keyword | 17 | 72% | 1% | 13 |
| 2 | PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX | Author keyword | 15 | 88% | 0% | 7 |
| 3 | PROT CRYSTALLOG UNIT | Address | 9 | 25% | 2% | 31 |
| 4 | PEPTIDE MHC COMPLEXES | Author keyword | 9 | 83% | 0% | 5 |
| 5 | V ALPHA DOMAIN | Author keyword | 9 | 83% | 0% | 5 |
| 6 | TCR ANTAGONISM | Author keyword | 8 | 75% | 0% | 6 |
| 7 | MOL STAT BIOINFORMAT SECT | Address | 7 | 67% | 0% | 6 |
| 8 | ALTERED PEPTIDE LIGAND | Author keyword | 7 | 31% | 1% | 18 |
| 9 | T CELL MODULAT GRP | Address | 6 | 80% | 0% | 4 |
| 10 | ALTERED PEPTIDE LIGANDS | Author keyword | 5 | 29% | 1% | 16 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PEPTIDE MHC | 17 | 72% | 1% | 13 | Search PEPTIDE+MHC | Search PEPTIDE+MHC |
| 2 | PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX | 15 | 88% | 0% | 7 | Search PEPTIDE+MAJOR+HISTOCOMPATIBILITY+COMPLEX | Search PEPTIDE+MAJOR+HISTOCOMPATIBILITY+COMPLEX |
| 3 | PEPTIDE MHC COMPLEXES | 9 | 83% | 0% | 5 | Search PEPTIDE+MHC+COMPLEXES | Search PEPTIDE+MHC+COMPLEXES |
| 4 | V ALPHA DOMAIN | 9 | 83% | 0% | 5 | Search V+ALPHA+DOMAIN | Search V+ALPHA+DOMAIN |
| 5 | TCR ANTAGONISM | 8 | 75% | 0% | 6 | Search TCR+ANTAGONISM | Search TCR+ANTAGONISM |
| 6 | ALTERED PEPTIDE LIGAND | 7 | 31% | 1% | 18 | Search ALTERED+PEPTIDE+LIGAND | Search ALTERED+PEPTIDE+LIGAND |
| 7 | ALTERED PEPTIDE LIGANDS | 5 | 29% | 1% | 16 | Search ALTERED+PEPTIDE+LIGANDS | Search ALTERED+PEPTIDE+LIGANDS |
| 8 | ANTIGEN RECOGNITION | 5 | 21% | 1% | 22 | Search ANTIGEN+RECOGNITION | Search ANTIGEN+RECOGNITION |
| 9 | IN SITU TETRAMER STAINING | 4 | 75% | 0% | 3 | Search IN+SITU+TETRAMER+STAINING | Search IN+SITU+TETRAMER+STAINING |
| 10 | PMHC | 4 | 75% | 0% | 3 | Search PMHC | Search PMHC |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PEPTIDE MHC | 120 | 67% | 6% | 108 |
| 2 | TCR BINDING | 74 | 79% | 3% | 48 |
| 3 | ANTAGONIST LIGANDS | 51 | 70% | 3% | 42 |
| 4 | MHC COMPLEXES | 43 | 57% | 3% | 51 |
| 5 | PEPTIDE MHC COMPLEXES | 42 | 39% | 5% | 85 |
| 6 | TCR | 39 | 20% | 11% | 180 |
| 7 | RESTRICTED SPECIFICITY | 34 | 93% | 1% | 13 |
| 8 | CD8 CORECEPTOR | 34 | 79% | 1% | 22 |
| 9 | HUMAN RECOMBINANT ANTIBODIES | 27 | 66% | 2% | 25 |
| 10 | ANTIGEN RECOGNITION | 26 | 21% | 7% | 109 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules | 2015 | 7 | 144 | 59% |
| How TCRs bind MHCs, peptides, and coreceptors | 2006 | 489 | 145 | 38% |
| Mechanisms for T cell receptor triggering | 2011 | 88 | 99 | 42% |
| T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity | 2009 | 79 | 104 | 73% |
| Ligand recognition by alpha beta T cell receptors | 1998 | 573 | 80 | 45% |
| Insights into the initiation of TCR signaling | 2014 | 15 | 95 | 37% |
| T cell receptor-MHC interactions up close | 2001 | 94 | 15 | 100% |
| An induced rebinding model of antigen discrimination | 2014 | 5 | 39 | 72% |
| Class II major histocompatibility complex tetramer staining: progress, problems, and prospects | 2008 | 54 | 94 | 59% |
| Mathematical and computational models of immune-receptor signalling | 2004 | 106 | 80 | 45% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PROT CRYSTALLOG UNIT | 9 | 25% | 1.9% | 31 |
| 2 | MOL STAT BIOINFORMAT SECT | 7 | 67% | 0.4% | 6 |
| 3 | T CELL MODULAT GRP | 6 | 80% | 0.2% | 4 |
| 4 | HUMAN IMMUN | 5 | 63% | 0.3% | 5 |
| 5 | SECT BIOSIMULAT BIOINFORMAT | 5 | 63% | 0.3% | 5 |
| 6 | LAUSANNE BRANCH | 5 | 10% | 2.6% | 43 |
| 7 | MOL IMMUNOL SECT | 3 | 18% | 1.0% | 17 |
| 8 | BIOMED COMP SIMULAT BIOINFORMAT | 3 | 100% | 0.2% | 3 |
| 9 | SECT BIOMED COMP SIMULAT BIOINFORMAT | 3 | 100% | 0.2% | 3 |
| 10 | PROGRAM BIOMOL STRUCT | 3 | 23% | 0.7% | 11 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000175655 | IMMUNOLOGICAL SYNAPSE//LYMPHOCYTE INTERACT//PROGRAM MOL PATHOGENESIS |
| 2 | 0.0000162690 | CELLULAR INJURY//TCR ZETA CHAIN//CD3 GAMMA |
| 3 | 0.0000143794 | T CELL DEVELOPMENT//PRE T CELL RECEPTOR//THYMIC SELECTION |
| 4 | 0.0000132627 | TAPASIN//TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING//PEPTIDE LOADING COMPLEX |
| 5 | 0.0000111832 | MED HOWARD HUGHES MED PATHOL//CD8 BETA//CD8 IMMUNODEFICIENCY |
| 6 | 0.0000109246 | INTERDISCIPLINARY PROGRAM IMMUNOL//INTEGRATED IMMUNOL VACCINE//T CELL COMPETITION |
| 7 | 0.0000092509 | SPECTRATYPING//CDR3//T CELL REPERTOIRE |
| 8 | 0.0000091120 | IMGT//UPR CNRS 1142//CNRSUPR 1142 |
| 9 | 0.0000088246 | SECRETION INHIBITION//RNF13//PROTEASE ASSOCIATED DOMAIN |
| 10 | 0.0000086240 | CHIMERIC ANTIGEN RECEPTOR//ADOPTIVE CELL THERAPY//CHIMERIC IMMUNE RECEPTOR |